|
1
|
Xu Y, Cheng L, Dai H, Zhang R, Wang M, Shi
T, Sun M, Cheng X and Wei Q: Variants in Notch signalling pathway
genes, PSEN1 and MAML2, predict overall survival in Chinese
patients with epithelial ovarian cancer. J Cell Mol Med.
22:4975–4984. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oliveira-Ferrer L, Goswami R, Galatenko V,
Ding Y, Eylmann K, Legler K, Kürti S, Schmalfeldt B and
Milde-Langosch K: Prognostic impact of CEACAM1 in node-negative
ovarian cancer patients. Dis Markers. 2018:67142872018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rhyasen GW, Yao Y, Zhang J, Dulak A,
Castriotta L, Jacques K, Zhao W, Gharahdaghi F, Hattersley MM, Lyne
PD, et al: BRD4 amplification facilitates an oncogenic gene
expression program in high-grade serous ovarian cancer and confers
sensitivity to BET inhibitors. PLoS One. 13:e02008262018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Castro BG, Dos Reis R, Cintra GF, Sousa
MM, Vieira MA and Andrade CE: Predictive factors for surgical
morbidities and adjuvant chemotherapy delay for advanced ovarian
cancer patients treated by primary debulking surgery or interval
debulking surgery. Int J Gynecol Cancer. 28:1520–1528. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saxena P, Severi L, Santucci M, Taddia L,
Ferrari S, Luciani R, Marverti G, Marraccini C, Tondi D, Mor M, et
al: Conformational propensity and biological studies of proline
mutated LR peptides inhibiting human thymidylate synthase and
ovarian cancer cell growth. J Med Chem. 61:7374–7380. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shu C, Yan D, Mo Y, Gu J, Shah N and He J:
Long noncoding RNA lncARSR promotes epithelial ovarian cancer cell
proliferation and invasion by association with HuR and miR-200
family. Am J Cancer Res. 8:981–992. 2018.PubMed/NCBI
|
|
7
|
Coogan PF, Rosenberg L, Palmer JR, Strom
BL, Zauber AG and Shapiro S: Statin use and the risk of breast and
prostate cancer. Epidemiology. 13:262–267. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen P, Fang X, Xia B, Zhao Y, Li Q and Wu
X: Long noncoding RNA LINC00152 promotes cell proliferation through
competitively binding endogenous miR-125b with MCL-1 by regulating
mitochondrial apoptosis pathways in ovarian cancer. Cancer Med.
7:4530–4541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hong SS, Zhang MX, Zhang M, Yu Y, Chen J,
Zhang XY and Xu CJ: Follicle-stimulating hormone peptide-conjugated
nanoparticles for targeted shRNA delivery lead to effective gro-α
silencing and antitumor activity against ovarian cancer. Drug
Deliv. 25:576–584. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ahmad F, Shah K, Umair M, Irfanullah JA,
Khan S, Muhammad D, Basit S, Wakil SM, Ramzan K, et al: Novel
autosomal recessive LAMA3 and PLEC variants underlie junctional
epidermolysis bullosa generalized intermediate and epidermolysis
bullosa simplex with muscular dystrophy in two consanguineous
families. Clin Exp Dermatol. 43:752–755. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J, Wang H, Wang Y, Dong W, Jiang Z
and Yang G: Substrate-mediated gene transduction of LAMA3 for
promoting biological sealing between titanium surface and gingival
epithelium. Colloids Surf B Biointerfaces. 161:314–323. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Reimer A, Schwieger-Briel A, He Y, Leppert
J, Schauer F, Kiritsi D, Schneider H, Ott H, Bruckner-Tuderman L
and Has C: Natural history and clinical outcome of junctional
epidermolysis bullosa generalized intermediate due to a LAMA3
mutation. Br J Dermatol. 178:973–975. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gostyńska KB, Yan Yuen W, Pasmooij AM,
Stellingsma C, Pas HH, Lemmink H and Jonkman MF: Carriers with
functional null mutations in LAMA3 have localized enamel
abnormalities due to haploinsufficiency. Eur J Hum Genet. 25:94–99.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pesch M, König S and Aumailley M: Targeted
disruption of the Lama3 gene in adult mice is sufficient to induce
skin inflammation and fibrosis. J Invest Dermatol. 137:332–340.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arora E, Masab M, Jindal V, Riaz I, Gupta
S and Varadi G: Role of poly adenosine diphosphate ribose
polymerase inhibitors in advanced stage ovarian cancer. Cureus.
10:e26852018.PubMed/NCBI
|
|
16
|
Srinivas KG, Mirza AA, Swamy S, Amarendra
S and Kodaganur G: Metachronous synchronous sternal and colonic
metastasis with asymptomatic colo-colic fistula from carcinoma
ovary rare presentation of ovarian cancer. Indian J Surg Oncol.
8:615–618. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stone ML, Chiappinelli KB, Li H, Murphy
LM, Travers ME, Topper MJ, Mathios D, Lim M, Shih IM, Wang TL, et
al: Epigenetic therapy activates type I interferon signaling in
murine ovarian cancer to reduce immunosuppression and tumor burden.
Proc Natl Acad Sci USA. 114:E10981–E10990. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stemmler S, Parwez Q, Petrasch-Parwez E,
Epplen JT and Hoffjan S: Association of variation in the LAMA3
gene, encoding the alpha-chain of laminin 5, with atopic dermatitis
in a German case-control cohort. BMC Dermatol. 14:172014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lincoln V, Cogan J, Hou Y, Hirsch M, Hao
M, Alexeev V, De Luca M, De Rosa L, Bauer JW, Woodley DT, et al:
Gentamicin induces LAMB3 nonsense mutation readthrough and restores
functional laminin 332 in junctional epidermolysis bullosa. Proc
Natl Acad Sci USA. 115:E6536–E6545. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Svoboda M, Hlobilová M, Marešová M,
Sochorová M, Kováčik A, Vávrová K and Dolečková I: Comparison of
suction blistering and tape stripping for analysis of epidermal
genes, proteins and lipids. Arch Dermatol Res. 309:757–765. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shukla DK, Gupta D, Aggarwal A and Kumar
D: A case report of newly diagnosed epithelial ovarian carcinoma
presenting with spontaneous tumor lysis syndrome and its successful
management with rasburicase. Indian J Med Paediatr Oncol.
38:360–362. 2017. View Article : Google Scholar : PubMed/NCBI
|
